Pharmaceutical Development Government Contracts

AI Summary

The Department of Health and Human Services seeks a contractor for the synthesis of two specific chemical compounds for a Janus kinase 2 (JAK2) enzyme project. This non-competitive opportunity requires the compounds to be delivered at 95% purity within two months of order approval. The work will support brain cancer re…

AI Summary

The National Institute on Drug Abuse is seeking proposals from qualified organizations for the development and manufacture of pharmaceutical dosage forms aimed at treating substance use disorders. This includes formulation development, quality control, stability studies, and distribution for preclinical and clinical st…

AI Summary

The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) is seeking information on innovations in biologics manufacturing. This RFI invites capabilities related to cell-free production, process control, and technologies that enhance drug release times. Responses are vo…

AI Summary

The National Institutes of Health seeks proposals for tritium labeled ketamine metabolites, specifically R-ketamine, S-ketamine, and RR-HNK. This project aims to support pharmacological studies and requires 5 mCi of each compound for autoradiography work. The contract period is five months from the award date.

AI Summary

The Department of Health and Human Services is seeking proposals for the late-stage clinical development and regulatory approval of 2-PAM autoinjectors, a drug/device combination product for treating organophosphate poisoning. This solicitation aims to utilize Project Bioshield funds to enhance emergency preparedness c…

AI Summary

This opportunity involves the development of cryopreserved platelets for U.S. Food and Drug Administration licensure. The solicitation W81XWH19R0033 has been amended to address questions from potential offerors. Interested parties should review the attached documents for further details.